Investors
Our investors are more than financial partners. They share our vision for advancing precision medicine through innovation, scientific excellence, and long-term collaboration. Their support enables us to continue expanding our technologies, growing our global reach, and delivering greater value to researchers, clinicians, and healthcare organizations worldwide.
Backed by believers that a healthier tomorrow can be made possible through better body composition analysis
At AMRA Medical, collaboration is at the heart of progress. We are proud to work with partners across a wide range of sectors and therapeutic areas, uniting expertise from academia, industry, and clinical practice.
Our global alliances are built to deliver greater value, broader access, and best-in-class support, ensuring that every partnership drives meaningful impact. Together, we are advancing scientific innovation and shaping the future of precision medicine.
HealthCap is a European venture capital firm investing globally in life sciences since 1996. The firm has backed and built more than 130 companies, taken 48 public, and completed numerous trade sales. HealthCap’s investment strategy targets diseases with a high unmet medical need, backing breakthrough therapies and innovative healthcare solutions with the potential to be transformative, changing clinical practice and improving the lives of patients suffering from these conditions.
Industrifonden is Sweden’s Venture Capital Fund looking for unique, scalable innovation that has a meaningful impact on our society. Industrifonden manages more than SEK 5 billion and invests in early-stage companies, from seed to A-round funding with a reach across the Nordics. The investment focus includes specialized technologies and businesses within Deep Tech, Life Science and Transformative Tech. Industrifonden has an evergreen structure which allows a long-term focus on value creation.
